Skip to Main Content
Skip Nav Destination
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Adrenal androgen excess is found in adult female rhesus monkeys previously exposed to androgen treatmentduring early gestation. In adulthood, such prenatally androgenized female monkeys exhibit elevatedbasal circulating levels of dehydroepiandrosterone sulfate (DHEAS), typical of polycystic ovary syndrome(PCOS) women with adrenal androgen excess. Further androgen and glucocorticoid abnormalities in PAfemale monkeys are revealed by acute ACTH stimulation: DHEA, androstenedione and corticosteroneresponses are all elevated compared to responses in controls. Pioglitazone treatment, however, diminishescirculating DHEAS responses to ACTH in both prenatally androgenized and control female monkeys, whileincreasing the 17-hydroxyprogesterone response and reducing the DHEA to 17-hydroxyprogesterone ratio.Since 60-min post-ACTH serum values for 17-hydroxyprogesterone correlate negatively with basal seruminsulin levels (all female monkeys on pioglitazone and placebo treatment combined), while similar DHEASvalues correlate positively with basal serum insulin levels, circulating insulin levels may preferentially supportadrenal androgen biosynthesis in both prenatally androgenized and control female rhesus monkeys.Overall, our findings suggest that differentiation of the monkey adrenal cortex in a hyperandrogenic fetalenvironment may permanently upregulate adult adrenal androgen biosynthesis through specific elevationof 17,20-lyase activity in the zona fasciculata-reticularis. As adult prenatally androgenized female rhesusmonkeys closely emulate PCOS-like symptoms, excess fetal androgen programming may contribute toadult adrenal androgen excess in women with PCOS.

Send Email

Recipient(s) will receive an email with a link to 'Disorders of the Human Adrenal Cortex > 145 - 158: Fetal Programming of Adrenal Androgen Excess: Lessons from a Nonhuman Primate Model of Polycystic Ovary Syndrome' and will not need an account to access the content.

Subject: Disorders of the Human Adrenal Cortex > 145 - 158: Fetal Programming of Adrenal Androgen Excess: Lessons from a Nonhuman Primate Model of Polycystic Ovary Syndrome

(Optional message may have a maximum of 1000 characters.)

×

or Create an Account

Close Modal
Close Modal